SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study

The coronavirus disease (COVID-19) is spreading between human populations mainly through nasal droplets. Currently, the vaccines have great hope, but it takes years for testing its efficacy in human. As there is no specific drug treatment available for COVID-19 pandemic, we explored in silico repurp...

Descripción completa

Detalles Bibliográficos
Autores principales: Baby, Krishnaprasad, Maity, Swastika, Mehta, Chetan H., Suresh, Akhil, Nayak, Usha Y., Nayak, Yogendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060391/
https://www.ncbi.nlm.nih.gov/pubmed/33539819
http://dx.doi.org/10.1016/j.ejphar.2021.173922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060391/
https://www.ncbi.nlm.nih.gov/pubmed/33539819
http://dx.doi.org/10.1016/j.ejphar.2021.173922

Ejemplares similares